Skip to main content

In the News

In the News highlights media coverage featuring the Johns Hopkins Bloomberg School of Public Health.



FDA Approves Pfizer-BioNTech COVID-19 Vaccine

The Food and Drug Administration has given full approval to the Pfizer-BioNTech COVID-19 vaccine on Monday. This could help convince people who may have resisted the vaccine and lead to more mandates.

The Washington Post

The Case for Covid-19 Boosters Is as Shaky as Ever

Scientists are raising serious questions about the wisdom of the push for Covid-19 boosters unveiled on Wednesday by President Joe Biden. It’ll be hard to judge whether extra shots for the vaccinated will be helpful or counterproductive until more of the data behind the decision become available.


What’s safe to do during summer’s Covid surge? STAT asked public health experts about their own plans

The fully vaccinated have been told to resume wearing masks indoors. Companies and institutions are leveling vaccine mandates. And some municipalities are requiring people to show proof of vaccination to get into restaurants, bars, and gyms. Confusion abounds about what is safe to do. (For the unvaccinated, there’s no confusion about what’s most important to do: Get immunized.)

The Atlantic

The Coronavirus Is Here Forever. This Is How We Live With It.

That future may be hard to imagine with intensive-care units filling up yet again during this Delta surge. But the pandemic will end. One way or another, it will end. The current spikes in cases and deaths are the result of a novel coronavirus meeting naive immune systems.


Even Moderate COVID Restrictions Can Slow The Spread Of The Virus — If They're Timely

Tensions are high right now. As the delta variant spreads like wildfire across the U.S., vaccination rates are still low in many places and parents and school staff are anxiously wondering what will happen as schools start up again. Should there be more mask mandates? Will businesses have to close again? Will big gatherings be banned?


As Delta spreads, some travelers double up on COVID-19 vaccine in U.S.

A few countries are also beginning to offer a third booster dose to their citizens based on evidence that the initial protection from vaccines wanes over time, or that an extra shot may help prevent infection against Delta, particularly for older people or those with weak immune systems.